RGD Reference Report - GABAA receptors: structure, function, pharmacology, and related disorders. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

GABAA receptors: structure, function, pharmacology, and related disorders.

Authors: Ghit, Amr  Assal, Dina  Al-Shami, Ahmed S  Hussein, Diaa Eldin E 
Citation: Ghit A, etal., J Genet Eng Biotechnol. 2021 Aug 21;19(1):123. doi: 10.1186/s43141-021-00224-0.
RGD ID: 405650249
Pubmed: PMID:34417930   (View Abstract at PubMed)
PMCID: PMC8380214   (View Article at PubMed Central)
DOI: DOI:10.1186/s43141-021-00224-0   (Journal Full-text)


BACKGROUND: γ-Aminobutyric acid sub-type A receptors (GABAARs) are the most prominent inhibitory neurotransmitter receptors in the CNS. They are a family of ligand-gated ion channel with significant physiological and therapeutic implications.
MAIN BODY: GABAARs are heteropentamers formed from a selection of 19 subunits: six α (alpha1-6), three β (beta1-3), three γ (gamma1-3), three ρ (rho1-3), and one each of the δ (delta), ε (epsilon), π (pi), and θ (theta) which result in the production of a considerable number of receptor isoforms. Each isoform exhibits distinct pharmacological and physiological properties. However, the majority of GABAARs are composed of two α subunits, two β subunits, and one γ subunit arranged as γ2β2α1β2α1 counterclockwise around the center. The mature receptor has a central chloride ion channel gated by GABA neurotransmitter and modulated by a variety of different drugs. Changes in GABA synthesis or release may have a significant effect on normal brain function. Furthermore, The molecular interactions and pharmacological effects caused by drugs are extremely complex. This is due to the structural heterogeneity of the receptors, and the existence of multiple allosteric binding sites as well as a wide range of ligands that can bind to them. Notably, dysfunction of the GABAergic system contributes to the development of several diseases. Therefore, understanding the relationship between GABAA receptor deficits and CNS disorders thus has a significant impact on the discovery of disease pathogenesis and drug development.
CONCLUSION: To date, few reviews have discussed GABAA receptors in detail. Accordingly, this review aims to summarize the current understanding of the structural, physiological, and pharmacological properties of GABAARs, as well as shedding light on the most common associated disorders.




Biological Process

  
Object Symbol
Species
Term
Qualifier
Evidence
With
Notes
Source
Original Reference(s)
Gabra4Ratgamma-aminobutyric acid signaling pathway involved_inNAS PMID:34417930ComplexPortal 
Gabra6Ratgamma-aminobutyric acid signaling pathway involved_inNAS PMID:34417930ComplexPortal 
Gabrb2Ratgamma-aminobutyric acid signaling pathway involved_inNAS PMID:34417930ComplexPortal 
Gabrb3Ratgamma-aminobutyric acid signaling pathway involved_inNAS PMID:34417930ComplexPortal 
GabrdRatgamma-aminobutyric acid signaling pathway involved_inNAS PMID:34417930ComplexPortal 
Gabrg2Ratgamma-aminobutyric acid signaling pathway involved_inNAS PMID:34417930ComplexPortal 


Genes (Rattus norvegicus)
Gabra4  (gamma-aminobutyric acid type A receptor subunit alpha 4) Gabra6  (gamma-aminobutyric acid type A receptor subunit alpha6) Gabrb2  (gamma-aminobutyric acid type A receptor subunit beta 2)
Gabrb3  (gamma-aminobutyric acid type A receptor subunit beta 3) Gabrd  (gamma-aminobutyric acid type A receptor subunit delta) Gabrg2  (gamma-aminobutyric acid type A receptor subunit gamma 2)